Table 2.
| Initial diagnostic criteria for NIFTP | Revised diagnostic criteria for NIFTP | |
|---|---|---|
| Primary | Secondarya | |
| Encapsulation or clear demarcation | Encapsulation or clear demarcation | Lack of BRAF V600E mutation detected by molecular assays or immunohistochemistry |
| Follicular growth pattern with: <1% papillae No psammoma bodies <30% solid/trabecular/insular growth pattern Nuclear score, 2–3 No vascular or capsular invasion No tumour necrosis No high mitotic activity |
Follicular growth pattern with: No well-formed papillae No psammoma bodies <30% solid/trabecular/insular growth pattern Nuclear score, 2–3 No vascular or capsular invasion No tumour necrosis No high mitotic activity |
Lack of BRAF V600E-like mutations or other high-risk mutations (TERT, TP53) |
aSecondary criteria are helpful but not required for NIFTP diagnosis.
NIFTP, noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
This work is licensed under a